The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Open accessThe DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.
Abstract
Following the discovery of T helper 17 (TH17) cells, the past decade has witnessed a major revision of the TH subset paradigm and substantial progress has been made in deciphering the molecular mechanisms of T cell lineage commitment and function. In this Review, we focus on the recent advances that have been made regarding the transcriptional control of TH17 cell plasticity and stability, as well as the effector functions of TH17 cells, and we highlight the mechanisms of IL-17 signalling in mesenchymal and barrier epithelial tissues. We also discuss the emerging clinical data showing that IL-17-specific and IL-23-specific antibody treatments are remarkably effective for treating many immune-mediated inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17 induces IL-6 and G-CSF, cytokines that promote myeloid-driven innate inflammation”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Gaffen et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways
Kim, J. S., Sklarz, T., Banks, L. B., Gohil, M., Waickman, A. T., Skuli, N., Krock, B. L., Luo, C. T., Hu, W., Pollizzi, K. N., et al. (2013) · Nature Immunology · doi:10.1038/ni.2607 · Cited by 85
RetractedMosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Self-citationHarrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Self-citationVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Research works printed but not linked: 1
- Ghoreschi K Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling Nature 467 967 971 20962846 PMC3108066 · DOI · Paper page
Cited by
Items 601–700 of 1,000
Deubiquitylating enzymes: potential target in autoimmune diseases
Parihar, N., & Bhatt, L. K. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00890-z · Cited by 34
Basophil-derived IL-4 promotes cutaneous Staphylococcus aureus infection
Leyva-Castillo, J. M., Das, M., Kane, J., Strakosha, M., Singh, S., Wong, D. S. H., Horswill, A. R., Karasuyama, H., Brombacher, F., Miller, L. S., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.149953 · Cited by 34
“cytokines in the induction of IL-17A in inflammation, infections, and wound healing (16, 18, 19, 34).”
BackgroundKay, A. G., Treadwell, K., Roach, P., Morgan, R., Lodge, R. W., Hyland, M., Piccinini, A. M., Forsyth, N. R., & Kehoe, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010126 · Cited by 34
Valentin, A., Bergamaschi, C., Rosati, M., Angel, M., Burns, R., Agarwal, M., Gergen, J., Petsch, B., Oostvogels, L., Loeliger, E., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.945706 · Cited by 34
IL-23 signaling prevents ferroptosis-driven renal immunopathology during candidiasis
Millet, N., Solis, N. V., Aguilar, D., Lionakis, M. S., Wheeler, R. T., Jendzjowsky, N. G., & Swidergall, M. (2022) · Nature Communications · doi:10.1038/s41467-022-33327-4 · Cited by 35
Saviano, A., Mansour, A. A., Raucci, F., Merlino, F., Marigliano, N., Schettino, A., Wahid, M., Begum, J., Filer, A. D., Manning, J. E., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-224479 · Cited by 34
Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment
Flores‐Borja, F., Irshad, S., Gordon, P., Wong, F., Sheriff, I., Tutt, A. N. J., & Ng, T. (2016) · Journal of Immunology Research · doi:10.1155/2016/7803091 · Cited by 34
“IL-17 is an important cytokine linking both innate and adaptive immune responses in infection and autoimmunity [66].”
Steering of carcinoma progression by the YIN/YANG interaction of STAT1/STAT3
Friedrich, K., Dolznig, H., Han, X., & Moriggl, R. (2017) · BioScience Trends · doi:10.5582/bst.2016.01250 · Cited by 34
Immune responses to airborne fungi and non-invasive airway diseases
Vacher, G., Niculita-Hirzel, H., & Roger, T. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0471-3 · Cited by 33
IL-17A synergistically enhances TNFα-induced IL-6 and CCL20 production in 3T3-L1 adipocytes
Shinjo, T., Iwashita, M., Yamashita, A., Sano, T., Tsuruta, M., Matsunaga, H., Sanui, T., Asano, T., & Nishimura, F. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.049 · Cited by 33
Vitales‐Noyola, M., Layseca‐Espinosa, E., Baranda, L., Abud‐Mendoza, C., Niño-Moreno, P., Monsiváis-Urenda, A. E., Rosenstein, Y., & González‐Amaro, R. (2018) · Journal of Immunology Research · doi:10.1155/2018/9627806 · Cited by 33
“Accordingly, the cytokines that induce this cell subset as well as the cytokines synthesized by them have become therapeutic targets for the treatment of several inflammatory immune-mediated conditions [20].”
BackgroundShen, F., Verma, A. H., Volk, A. L., Jones, B. H., Coleman, B. M., Loza, M. J., Malaviya, R., Moore, B. A., Weinstock, D., Elloso, M. M., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801436 · Cited by 33
“synergize to trigger downstream inflammatory genes in target cells, which are mainly nonhematopoietic (5, 6, 8).”
BackgroundSelf-citationKe, K., Chen, T. (.-P., Arra, M., Mbalaviele, G., Swarnkar, G., & Abu‐Amer, Y. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3759 · Cited by 33
“It has been suggested that the IL23/IL17A inflammatory axis governs the cross‐talk between innate and adaptive immunity during gut inflammation and induces ILCs.”
ResultInfluentialKang, M., Lee, S., Park, Y. M., Kim, B. S., Lee, M.-J., Kim, J., Jeong, S., Lee, S., Park, M. J., Rhee, E. S., et al. (2021) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2021.13.3.404 · Cited by 33
Mortier, C., Gracey, E., Coudenys, J., Manuello, T., Decruy, T., Maelegheer, M., Stappers, F., Gilis, E., Gaublomme, D., Hoorebeke, L. V., et al. (2023) · Rheumatology · doi:10.1093/rheumatology/kead022 · Cited by 34
Mangan, P. R., Su, L. J., Jenny, V., Tatum, A. L., Picarillo, C., Skala, S., Ditto, N. T., Lin, Z., Yang, X., Cotter, P., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.224246 · Cited by 33
“However, in MS patients, the trials with anti-p40 antibodies failed (Segal et al., 2008; Longbrake and Racke, 2009; Sandborn et al., 2012; Kimball et al., 2013; Papp et al., 2013a; Gaffen et al., 2014).”
BackgroundInfluentialThe biology of IL-23 and IL-17 and their therapeutic targeting in rheumatic diseases
Sherlock, J. P., Taylor, P. C., & Buckley, C. D. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000132 · Cited by 33
“The discovery of the potent pro-inflammatory action of interleukin (IL)-23 and its key role in driving T-helper (Th17) cell pathogenicity created a novel field of inflammation research which is now leading the way towards a large range of novel therapeutic approaches [1].”
BackgroundIntegrative Phosphoproteomics Links IL-23R Signaling with Metabolic Adaptation in Lymphocytes
Lochmatter, C., Fischer, R., Charles, P. D., Yu, Z., Powrie, F. M., & Kessler, B. M. (2016) · Scientific Reports · doi:10.1038/srep24491 · Cited by 33
Wang, H., Bai, J., Luo, Z., Fu, J., Wang, H., & Sun, Z. (2017) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2017.04.003 · Cited by 33
Selective Interleukin-23 p19 Inhibition: Another Game Changer in Psoriasis? Focus on Risankizumab
Torres, T. R. (2017) · Drugs · doi:10.1007/s40265-017-0794-1 · Cited by 33
Liu, Q., Gao, Q., Zhang, Y., Li, Z., & Mei, X. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.123 · Cited by 33
Chamoun, M. N., Blumenthal, A., Sullivan, M. J., Schembri, M. A., & Ulett, G. C. (2018) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2018.1426556 · Cited by 32
“…and peripheral tissues, lymphoid organs), natural killer (NK) cells (gut and skin), invariant natural killer T (iNKT) cells (liver, lung, skin), and lymphoid-tissue inducer-like cells (lamina propria, spleen, gut, and skin) (Cua and Tato 2010; Sutton et al. 2012; Gaffen et al. 2014) (Figure 1(B)).”
BackgroundInfluentialApproaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes
Kopan, C., Tucker, T. R., Alexander, M., Mohammadi, M. R., Pone, E. J., & Lakey, J. R. T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01354 · Cited by 33
Yang, J.-Q., Kalim, K. W., Li, Y., Zheng, Y., & Guo, F. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0119-025rrr · Cited by 33
Diverse human VH antibody fragments with bio-therapeutic properties from the Crescendo Mouse
Teng, Y., Young, J. L., Edwards, B. M., Hayes, P., Thompson, L., Johnston, C. M., Edwards, C., Sanders, Y., Writer, M. J., Pinto, D., et al. (2019) · New Biotechnology · doi:10.1016/j.nbt.2019.10.003 · Cited by 32
Pathogenesis-oriented therapy of psoriasis using biologics
Boehncke, W., & Brembilla, N. C. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2100219 · Cited by 32
“to IL-23 is essential to induce the maturation of TH17 cells and drive their pathogenicity [40].”
BackgroundNeutrophils: Musketeers against immunotherapy
Zahid, K. R., Raza, U., Tumbath, S., Jiang, L., Xu, W., & Huang, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.975981 · Cited by 32
Meguro, K., Suzuki, K., Hosokawa, J., Sanayama, Y., Tanaka, S., Furuta, S., Ikeda, K., Takatori, H., Suto, A., Sakamoto, A., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39266 · Cited by 32
“levels of retinoic acid receptor–related orphan nuclear receptor gt and IL-17A, which are Th17 cell–related genes (45), in CD41 T cells from RA patients (data not”
BackgroundIL-17-driven intestinal fibrosis is inhibited by Itch-mediated ubiquitination of HIC-5
Paul, J., Singh, A. K., Kathania, M., Tsakem, E. L., Zeng, M., Basrur, V., Theiss, A. L., & Venuprasad, K. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.53 · Cited by 32
Plasticity and heterogeneity of Th17 in immune-mediated kidney diseases
Krebs, C. F., & Panzer, U. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.005 · Cited by 32
Nadeem, A., Al-Harbi, N. O., Alfardan, A. S., Ahmad, S. F., Alasmari, A. F., & Al‐Harbi, M. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.123 · Cited by 32
Ramani, K., Tan, R. J., Zhou, D. F., Coleman, B. M., Jawale, C. V., Liu, Y., & Biswas, P. S. (2018) · Mediators of Inflammation · doi:10.1155/2018/5103672 · Cited by 33
Lack of Ikaros Deregulates Inflammatory Gene Programs in T Cells
Ana, C. L. D., Arakcheeva, K., Agnihotri, P., Derosia, N. M., & Winandy, S. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801270 · Cited by 32
“IL-23 induces expression of both IFN-g and GM-CSF in Th17 cells, which likely contributes to this role (39, 43, 47).”
BackgroundExpansion, isolation and first characterization of bovine Th17 lymphocytes
Cunha, P., Vern, Y. L., Gitton, C., Germon, P., Foucras, G., & Rainard, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-52562-2 · Cited by 31
Bing, S. J., Lyu, C., Xu, B., Wandu, W. S., Hinshaw, S. J. H., Furumoto, Y., Caspi, R. R., Gadina, M., & Gery, I. (2020) · Molecular vision · Cited by 31
Finerenone Reduces Renal RORγt γδ T Cells and Protects against Cardiorenal Damage
Luettges, K., Bode, M., Diemer, J. N., Schwanbeck, J., Wirth, E. K., Klopfleisch, R., Kappert, K., Thiele, A., Ritter, D., Foryst‐Ludwig, A., et al. (2022) · American Journal of Nephrology · doi:10.1159/000524940 · Cited by 31
Apolit, C., Campos, N., Vautrin, A., Begon‐Pescia, C., Lapasset, L., Scherrer, D., Gineste, P., Ehrlich, H. J., Garcel, A., Santo, J., et al. (2022) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000560 · Cited by 31
Venken, K., & Elewaut, D. S. (2015) · Current Rheumatology Reports · doi:10.1007/s11926-015-0507-2 · Cited by 31
Contreras‐Ruiz, L., Mir, F. A., Turpie, B., & Masli, S. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12919 · Cited by 31
Wang, Y., Balvers, M. G. J., Hendriks, H., Wilpshaar, T. A., van Heek, N. T., Witkamp, R. F., & Meijerink, J. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.05.008 · Cited by 31
Inhibition of ROCK activity regulates the balance of Th1, Th17 and Treg cells in myasthenia gravis
Song, J., Xi, J., Yu, W., Yan, C., Luo, S.-S., Zhou, L., Zhu, W., Lu, J., Dong, Q., Xiao, B., et al. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.05.006 · Cited by 31
A joint effort: The interplay between the innate and the adaptive immune system in Lyme arthritis
Brouwer, M. A. E., van de Schoor, F. R., Vrijmoeth, H. D., Netea, M. G., & Joosten, L. A. B. (2020) · Immunological Reviews · doi:10.1111/imr.12837 · Cited by 31
Update on non-infectious uveitis treatment: anti-TNF-alpha and beyond
Chauhan, K., & Tyagi, M. (2024) · Frontiers in Ophthalmology · doi:10.3389/fopht.2024.1412930 · Cited by 30
Proft, F. N., Duran, T. İ., Ghoreschi, K., Pleyer, U., Siegmund, B., & Poddubnyy, D. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103638 · Cited by 30
Khatri, A., Cheng, L., Camez, A. A., Ignatenko, S., Pang, Y., & Othman, M. I. A. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0730-x · Cited by 30
The Immunomodulator 1-Methyltryptophan Drives Tryptophan Catabolism Toward the Kynurenic Acid Branch
Wirthgen, E., Leonard, A. K., Scharf, C., & Domańska, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00313 · Cited by 30
Roles of Ubiquitination and Deubiquitination in Regulating Dendritic Cell Maturation and Function
Zhu, B., Zhu, L., Xia, L., Xiong, Y., Yin, Q., & Rui, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586613 · Cited by 30
Szandruk-Bender, M., Rutkowska, M., Merwid‐Ląd, A., Wiatrak, B., Szeląg, A., Dzimira, S., Sobieszczańska, B., Krzystek‐Korpacka, M., Kucharska, A. Z., Matuszewska, A., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7697851 · Cited by 30
“Moreover, IL-23 stimulates Th17 and ILCs to produce TNF-α, granulocyte-macrophage colony-stimulating factor (GMCSF), and several chemokines leading to immune response induction and inflammatory cell infiltration [49].”
BackgroundElevated IL-38 inhibits IL-23R expression and IL-17A production in thyroid-associated ophthalmopathy
Pan, Y., Wang, M., Chen, X., Chen, Y., Ai, S., Wang, M., Su, W., & Liang, D. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107300 · Cited by 30
Shamsi, M. M., Maryam, J., Bakhshi, B., Neda, F., Mokhtarzade, M., Mahboobeh, B., Quinn, L. S., & Kalani, B. S. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1871763 · Cited by 30
Cell‐intrinsic and ‐extrinsic roles of miRNAs in regulating T cell immunity
Cho, S., Dong, J., & Lu, L. (2021) · Immunological Reviews · doi:10.1111/imr.13029 · Cited by 32
Roles for Selenoprotein I and Ethanolamine Phospholipid Synthesis in T Cell Activation
Ma, C., Martinez‐Rodriguez, V., & Hoffmann, P. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011174 · Cited by 30
“Th17 cells are required for immune responses to specific extracellular bacteria and fungi [55], but dysregulated Th17 responses may also contribute to pathogenesis in autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis (MS) [56,57].”
BackgroundThe role of metabolism in Th17 cell differentiation and autoimmune diseases
Wang, G., Su, Z., Li, H. J., Xiao, L., Li, C., & Lian, G. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108450 · Cited by 30
Crowley, J., Langley, R. G. B., Gordon, K. B., Pinter, A., Ferris, L. K., Rubant, S., Photowala, H., Xue, Z., Wu, T., Zhan, T., et al. (2022) · Dermatology and Therapy · doi:10.1007/s13555-021-00679-6 · Cited by 30
“IL-23 aids in driving psoriasis by inducing the proliferation, differentiation, and maintenance of T-helper-17 and innate immune cells that produce proinflammatory cytokines, including IL-17 and IL-22, where reductions in these cytokines are observed in psoriatic lesions when inhibiting IL-23 [12, 14].”
BackgroundInfluentialTh17 cells and their related cytokines: vital players in progression of malignant pleural effusion
Niu, Y., & Zhou, Q. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04227-z · Cited by 30
“IL-1β, TGF-β, IL-6, IL-23, cytokines involved in generation, differentiation and expansion of Th17 cells [15, 18, 19].”
BackgroundInfluentialHow does Hashimoto’s thyroiditis affect bone metabolism?
Wu, J., Huang, H., & Yu, X. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09778-x · Cited by 30
Inborn Errors in Immunity: Unique Natural Models to Dissect Oral Immunity
Moutsopoulos, N. M., Lionakis, M. S., & Hajishengallis, G. (2015) · Journal of Dental Research · doi:10.1177/0022034515583533 · Cited by 30
Ixekizumab: a new anti-IL-17A monoclonal antibody therapy for moderate-to severe plaque psoriasis
Blauvelt, A. (2016) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1132695 · Cited by 30
“branes of many different cell types, including skin keratinocytes, other epithelial cells, endothelial cells, fibroblasts, and synoviocytes.[15] Surface binding by”
BackgroundInfluentialShimizu, J., Takai, K., Takada, E., Fujiwara, N., Arimitsu, N. N., Ueda, Y., Wakisaka, S., Tomoko, S., & Suzuki, N. (2015) · Clinical Rheumatology · doi:10.1007/s10067-015-2966-2 · Cited by 30
Regulation of Th17 Differentiation by IKKα-Dependent and -Independent Phosphorylation of RORγt
He, Z., Wang, F., Zhang, J., Sen, S., Pang, Q., Luo, S., Gwack, Y., & Sun, Z. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700457 · Cited by 30
Cytokine targeting in rheumatoid arthritis
Bui, V. L., & Brahn, E. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.04.001 · Cited by 31
Toussirot, É., Béreau, M., Vauchy, C., & Saas, P. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00440 · Cited by 30
“Indeed, Th17 cells represent heterogeneous Th cell subsets with pathogenic Th17 cells and regulatory anti-inflammatory Th17 cells (Gaffen et al., 2014).”
BackgroundInfluentialSerum Levels of Interleukin - 23 and Interleukin - 17 in Hashimoto’s Thyroiditis
Gerenova, J. B., Manolova, I., & Stanilova, S. (2019) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2019.74 · Cited by 30
“(7) has shown that the signalling induced by interleukin (IL) 23 on Th17 cells is crucial to obtain a pathogenic and sustained phenotype.”
BackgroundSmall-Molecule Antagonist Targeting Exportin-1 via Rational Structure-Based Discovery
Tian, X., Gao, J., Liu, M., Lei, Y., Wang, F., Chen, J., Chu, P., Gao, J., Long, F., Liang, M., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01663 · Cited by 30
IL-23 in arthritic and inflammatory pain development in mice
Lee, M.-C., Zhang, Z., Achuthan, A. A., Fleetwood, A. J., Smith, J. E., Hamilton, J. A., & Cook, A. D. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02212-0 · Cited by 30
The HSP90 inhibitor RGRN‐305 exhibits strong immunomodulatory effects in human keratinocytes
Hansen, R. S., Thuesen, K. K. H., Bregnhøj, A., Moldovan, L. I., Kristensen, L. S., Grek, C. L., Ghatnekar, G. S., Iversen, L., & Johansen, C. (2021) · Experimental Dermatology · doi:10.1111/exd.14302 · Cited by 30
Essential role of IL-23 in the development of acute exacerbation of pulmonary fibrosis
Senoo, S., Taniguchi, A., Itano, J., Oda, N., Morichika, D., Fujii, U., Guo, L., Sunami, R., Kanehiro, A., Tokioka, F., et al. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00582.2020 · Cited by 30
IL-17 Signaling Triggers Degradation of the Constitutive NF-κB Inhibitor ABIN-1
Cruz, J. A., Childs, E. E., Amatya, N., Garg, A. V., Beyaert, R., Kane, L. P., Aneskievich, B. J., Ma, A., & Gaffen, S. L. (2017) · ImmunoHorizons · doi:10.4049/immunohorizons.1700035 · Cited by 29
“IL-17 blocking therapies have shown considerable efficacy in treating psoriatic patients, and are being evaluated for various other conditions (2).”
BackgroundSelf-citationAlterations of gut microbiota for the onset and treatment of psoriasis: A systematic review
Xue, M., Deng, Q., Deng, L., Xun, T., Huang, T., Zhao, J., Wei, S., Zhao, C., Chen, X., Zhou, Y., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177521 · Cited by 30
Formanowicz, D., Gutowska, K., & Formanowicz, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113476 · Cited by 29
“Module (r) The role of IL-1, IL-23, IL-6, high level of IL-10 and IL-12 (released by classically activated macrophages M1): These cytokines are produced by several innate and myeloid immune cells including macrophages and dendritic cells [52].”
BackgroundWu, B., Zhang, S., Guo, Z., Wang, G., Zhang, G., Xie, L., Lou, J., Chen, X., Wu, D., Bergmeier, W., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.004 · Cited by 31
“In addition, the molecular programs of pathogenic and non-pathogenic Th17 cell are quite different (Gaffen et al., 2014; Lee et al., 2012).”
MCPIP1 RNase and Its Multifaceted Role
Musson, R., Szukała, W., & Jura, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197183 · Cited by 29
“Similar to the results obtained with IL-36, IL-17 dysregulation has been implicated in skin conditions, and antibody drugs targeting IL-17 have shown encouraging success in psoriasis treatment [86].”
ResultHe, R.-R., Wu, S., Gao, R., Chen, J., Peng, Q., Hu, H., Zhu, L., Du, Y., Sun, W., Ma, X., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001223 · Cited by 29
The IL-12 family cytokines in fish: Molecular structure, expression profile and function
Wang, X., Zhang, A., Qiu, X., YANG, K. Y., & Zhou, H. Y. (2023) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2023.104643 · Cited by 29
Maïer, B., Tsai, A. S., Einhaus, J. F., Désilles, J., Ho‐Tin‐Noé, B., Gory, B., Sirota, M., Leigh, R. J., Lemmens, R., Albers, G. W., et al. (2023) · Seminars in Immunopathology · doi:10.1007/s00281-023-00984-6 · Cited by 29
Lai, W., Huang, Z., Li, S., Li, X.-G., & Luo, D. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109840 · Cited by 31
Factors impacting the benefits and pathogenicity of Th17 cells in the tumor microenvironment
Xing, J., Man, C., Liu, Y., Zhang, Z., & Peng, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1224269 · Cited by 29
Kim, S.-H., Burton, J. H., Yu, C., Sun, L., He, C., Wang, H., Morse, H. C., & Egwuagu, C. E. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500653 · Cited by 29
“tures during Th cell differentiation (40, 41).”
Noll, J., Helk, E., Fehling, H., Bernin, H., Marggraff, C., Jacobs, T., Huber, S., Pelczar, P., Ernst, T., Ittrich, H., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.013 · Cited by 29
“IL-23 induces the IL-17 family members IL-17A and IL-17F in Th17 cells, as well as a unique inflammatory gene signature that contributes to the pathogenesis of autoimmunity [2].”
BackgroundEpidermal filaggrin deficiency mediates increased systemic T-helper 17 immune response
Bonefeld, C. M., Petersen, T. H., Bandier, J., Agerbeck, C., Linneberg, A. R., Ross‐Hansen, K., Stender, S., Szecsi, P. B., Johansen, J. D., Geisler, C., et al. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14570 · Cited by 29
de Lima, K. A., Donate, P. B., Talbot, J., Davoli-Ferreira, M., Peres, R. S., Cunha, T. M., Alves-Filho, J. C., & Cunha, F. Q. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1107-7 · Cited by 29
Chuang, H., Chen, Y., Chen, M., Hung, W., Yang, H., Tseng, Y.-H., & Tan, T. (2019) · The FASEB Journal · doi:10.1096/fj.201900105rr · Cited by 29
“dylitis (7, 8); however, development of therapeutic”
BackgroundRegulation of IL-17 in atherosclerosis and related autoimmunity
Ryu, H., & Chung, Y. (2015) · Cytokine · doi:10.1016/j.cyto.2015.03.009 · Cited by 30
The Role of IL-17 in Systemic Autoinflammatory Diseases: Mechanisms and Therapeutic Perspectives
Zhang, J., & Shen, M. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09042-5 · Cited by 28
“IL-23, known for its pro-inflammatory effects, enhances IL-17 secretion and supports memory CD4 + T cell proliferation, forming the IL-23/IL-17 axis that drives immune activation [33–35].”
Skin immune microenvironment in psoriasis: from bench to bedside
Yao, Y., Chen, L., Lv, Y., Tang, S.-L., Shen, W., Sun, H., & Zhong, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1643418 · Cited by 29
“This cytokine plays a central role in immune-mediated chronic in fl ammatory diseases, including psoriasis, psoriatic arthritis, Crohn ’ s disease, and uveitis, exerting broad immunopathologic effects (86).”
B7-H3: A promising therapeutic target for autoimmune diseases
Chen, Y., Guan, S., Deng, J., Yang, H., Xu, W., Xu, S., Shao, M., Gao, X., Xu, S., Shuai, Z., et al. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104077 · Cited by 28
Kang, S., Wu, Q., Yang, B., & Wu, C. Y. (2022) · The FASEB Journal · doi:10.1096/fj.202101443rr · Cited by 28
Krishnan, J., de la Visitación, N., Hennen, E. M., Amarnath, V., Harrison, D. G., & Patrick, D. M. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19305 · Cited by 28
Lu, Y., Ma, Q., Yu, L., Huang, H., Liu, X., Chen, P., Ran, H., & Liu, W. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109693 · Cited by 28
Wang, R., Oliveira, L. V. N., Lourenco, D., Gomez, C. L., Lee, C. K., Hester, M. M., Mou, Z., Ostroff, G. R., Specht, C. A., & Levitz, S. M. (2023) · npj Vaccines · doi:10.1038/s41541-023-00606-0 · Cited by 28
Shalaby, M., Abdelaziz, R. R., Ghoneim, H. A., & Suddek, G. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121596 · Cited by 28
Chauhan, A., Moore, T. L., Bi, Y., & Chen, C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.684795 · Cited by 28
“Csf2, IL-2, and Tbx21 are markers for the terminally differentiated pathogenic TH17 population (30).”
BackgroundPoland, M., ten Klooster, J. P., Wang, Z., Pieters, R. H. H., Boekschoten, M. V., Witkamp, R. F., & Meijerink, J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.09.012 · Cited by 28
Giunta, A., Ventura, A., Chimenti, M. S., Bianchi, L., & Esposito, M. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s92128 · Cited by 28
“Role of iL-17 in the pathogenesis of plaque-type psoriasis IL-17 is a family of proinflammatory cytokines first described by Yao et al and comprising IL-17A, IL-17B, IL-17C, IL-17D, IL-17E, and IL-17F secreted by T cells, natural killer cells, mast cells, and neutrophils.(11,12) IL-17A represents the most investigated…”
BackgroundEffect of Homocysteine on the Differentiation of CD4+ T Cells into Th17 Cells
Gao, X., Li, J., & Chen, M. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5177-2 · Cited by 28
Maximizing the Utility of Transcriptomics Data in Inflammatory Skin Diseases
Wu, J., Fang, Z., Liu, T., Hu, W., Wu, Y., & Li, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.761890 · Cited by 28
“Similarly, IL17-RA, IL-12/IL-23, or TNF inhibition treatments, were found to mainly affect the expression of IL-17 dependent genes, which further confirmed the hypothesis that IL17 -stimulated KCs were key drivers of psoriasis (19, 74).”
BackgroundCould the inhibition of IL-17 or IL-18 be a potential therapeutic opportunity for gastric cancer?
Nguyen, P. M., & Putoczki, T. L. (2018) · Cytokine · doi:10.1016/j.cyto.2018.01.008 · Cited by 28
Insights into the Pathogenesis of Pyoderma Gangrenosum
Becker, S., Vague, M., & Ortega‐Loayza, A. G. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.09.023 · Cited by 27
Follistatin‐like protein 1 modulates IL‐17 signaling via IL‐17RC regulation in stromal cells
Campfield, B. T., Eddens, T. J., Henkel, M., Majewski, M., Horne, W. T., Chaly, Y., Gaffen, S. L., Hirsch, R., & Kolls, J. K. (2017) · Immunology and Cell Biology · doi:10.1038/icb.2017.26 · Cited by 27
Self-citationBenešová, Y., Vašků, A., & Vašků, J. B. (2018) · Acta Neurologica Belgica · doi:10.1007/s13760-018-0994-9 · Cited by 27
Metadata
- Authors
- Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Cua, Daniel J.
- Venue
- Nature reviews. Immunology
- Published
- 2014-08-22
- Volume
- 14
- Issue
- 9
- Pages
- 585-600
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC4281037
- OpenAlex
- W2064645845
- Cited by
- 1,585
- References
- 187
- Citations by year
- 2026: 119 · 2025: 104 · 2024: 111 · 2023: 126 · 2022: 118 · 2021: 159 · 2020: 162 · 2019: 131 · 2018: 153 · 2017: 155 · 2016: 129 · 2015: 111 · 2014: 6
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI107825, AI107825)
- National Institute of Dental and Craniofacial Research (R01DE022550, R01DE023815, DE022550)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-23, IL-17, Th17 cells, T cell lineage commitment, transcriptional regulation, IL-17 signaling, mesenchyme, immune-mediated inflammatory diseases, therapeutic antibodies
- MeSH terms
- Antibodies, Autoimmune Diseases, Epithelial Cells, Humans, Transcription, Genetic, Signal Transduction, Cytokines, Tight Junctions, Interleukin-17, Receptors, Interleukin-17, Interleukin-23, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.